CN109674014A - Composition and production method for jasmine tea halogen - Google Patents
Composition and production method for jasmine tea halogen Download PDFInfo
- Publication number
- CN109674014A CN109674014A CN201910098965.1A CN201910098965A CN109674014A CN 109674014 A CN109674014 A CN 109674014A CN 201910098965 A CN201910098965 A CN 201910098965A CN 109674014 A CN109674014 A CN 109674014A
- Authority
- CN
- China
- Prior art keywords
- parts
- tea
- adjuvant
- jasmine
- main ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 404
- 235000010254 Jasminum officinale Nutrition 0.000 title claims abstract description 105
- 240000005385 Jasminum sambac Species 0.000 title claims abstract description 105
- 239000000203 mixture Substances 0.000 title claims abstract description 78
- 229910052736 halogen Inorganic materials 0.000 title claims abstract description 73
- 150000002367 halogens Chemical class 0.000 title claims abstract description 73
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 235000013616 tea Nutrition 0.000 claims abstract description 331
- 239000002075 main ingredient Substances 0.000 claims abstract description 115
- 239000002671 adjuvant Substances 0.000 claims abstract description 113
- 235000009569 green tea Nutrition 0.000 claims abstract description 58
- 235000019082 Osmanthus Nutrition 0.000 claims abstract description 51
- 241000333181 Osmanthus Species 0.000 claims abstract description 51
- 239000002994 raw material Substances 0.000 claims abstract description 34
- 239000009636 Huang Qi Substances 0.000 claims abstract description 33
- 235000021282 Sterculia Nutrition 0.000 claims abstract description 31
- 229940059107 sterculia Drugs 0.000 claims abstract description 31
- 240000001058 Sterculia urens Species 0.000 claims abstract description 30
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 30
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims abstract description 30
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 30
- 229910052737 gold Inorganic materials 0.000 claims abstract description 30
- 239000010931 gold Substances 0.000 claims abstract description 30
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 27
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 27
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 26
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 26
- 241000169546 Lycium ruthenicum Species 0.000 claims abstract description 26
- 240000004153 Hibiscus sabdariffa Species 0.000 claims abstract description 25
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 claims abstract description 25
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 21
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims description 43
- 240000001592 Amaranthus caudatus Species 0.000 claims description 32
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims description 32
- 239000004178 amaranth Substances 0.000 claims description 32
- 235000012735 amaranth Nutrition 0.000 claims description 32
- 241000756943 Codonopsis Species 0.000 claims description 31
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 30
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 30
- 240000000249 Morus alba Species 0.000 claims description 30
- 235000008708 Morus alba Nutrition 0.000 claims description 30
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 29
- 244000111489 Gardenia augusta Species 0.000 claims description 28
- 235000006468 Thea sinensis Nutrition 0.000 claims description 26
- 235000020279 black tea Nutrition 0.000 claims description 26
- 235000020334 white tea Nutrition 0.000 claims description 26
- 235000020338 yellow tea Nutrition 0.000 claims description 26
- 241000234435 Lilium Species 0.000 claims description 25
- 241000218378 Magnolia Species 0.000 claims description 25
- 235000014347 soups Nutrition 0.000 claims description 23
- 238000004140 cleaning Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 13
- 235000013547 stew Nutrition 0.000 claims description 11
- 238000001802 infusion Methods 0.000 claims description 10
- 230000000144 pharmacologic effect Effects 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 44
- 239000012267 brine Substances 0.000 abstract description 8
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 abstract description 8
- 240000008866 Ziziphus nummularia Species 0.000 description 19
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 208000004880 Polyuria Diseases 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 230000036772 blood pressure Effects 0.000 description 8
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 7
- 229960001948 caffeine Drugs 0.000 description 7
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 7
- 239000012535 impurity Substances 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 6
- 244000062793 Sorghum vulgare Species 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 235000019713 millet Nutrition 0.000 description 6
- 230000001151 other effect Effects 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- -1 because they think Chemical compound 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000035622 drinking Effects 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000004224 protection Effects 0.000 description 5
- 229910052709 silver Inorganic materials 0.000 description 5
- 239000004332 silver Substances 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 208000024827 Alzheimer disease Diseases 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 229940124277 aminobutyric acid Drugs 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 235000001465 calcium Nutrition 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 230000007661 gastrointestinal function Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000001771 mentha piperita Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 229940026510 theanine Drugs 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- KJXSIXMJHKAJOD-LSDHHAIUSA-N (+)-dihydromyricetin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC(O)=C(O)C(O)=C1 KJXSIXMJHKAJOD-LSDHHAIUSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010057071 Rectal tenesmus Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000489523 Veratrum Species 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000012271 tenesmus Diseases 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 244000235603 Acacia catechu Species 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000034710 Cerebral arteriovenous malformation Diseases 0.000 description 1
- 206010059109 Cerebral vasoconstriction Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Chemical group 0.000 description 1
- 208000002263 Intracranial Arteriovenous Malformations Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 244000242564 Osmanthus fragrans Species 0.000 description 1
- 235000019083 Osmanthus fragrans Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010033647 Pancreatitis acute Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 244000089698 Zanthoxylum simulans Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000003229 acute pancreatitis Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 201000000034 arteriovenous malformations of the brain Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- KQILIWXGGKGKNX-UHFFFAOYSA-N dihydromyricetin Natural products OC1C(=C(Oc2cc(O)cc(O)c12)c3cc(O)c(O)c(O)c3)O KQILIWXGGKGKNX-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000011224 negative regulation of urine volume Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002926 oxygen Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000036417 physical growth Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/11—Natural spices, flavouring agents or condiments; Extracts thereof obtained by solvent extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides the composition and production method for jasmine tea halogen, solve the problems, such as that existing brine effect is single；Composition for jasmine tea halogen, raw material is in parts by weight, including main ingredient and adjuvant, main ingredient includes 40-60 parts of dark green tea, 40-60 parts of green tea, 40-60 parts of jasmine tea, 40-60 parts of osmanthus flower tea, 40-60 parts of tartary buckwheat tea, 40-60 parts of spun gold emperor's chrysanthemum tea, 20-40 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, 20-40 parts of Siraitia grosvenorii, 20-40 parts of Radix Glycyrrhizae, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali, 20-40 parts of the sterculia seed and Radix Ophiopogonis 90-110 part；In use, main ingredient: adjuvant=1.5-2.5.The effect of tealeaves and other components are added in brine, increase brine by the composition and production method for jasmine tea halogen of the invention.
Description
Technical field
The invention belongs to spiced and stewed food technical fields, and in particular to composition and production method for jasmine tea halogen.
Background technique
Brine is that a kind of common seasoning, material therefor have Chinese prickly ash, eight in Chinese Guangdong dishes, Sichuan cuisine and many snacks
Angle, dried orange peel, cassia bark, Radix Glycyrrhizae, tsaoko, husky ginger, ginger, green onion, light soy sauce, dark soy sauce and rock sugar etc. are a variety of, and meat and fish dishes a few hours can be made into.Very
More restaurants can reuse brine, because they think, brine boils more long, just more delicious.Existing brine composition is fixed,
Effect is single.
Summary of the invention
It is an object of that present invention to provide the compositions and production method for jasmine tea halogen, solve existing brine effect list
One the problem of.
The technical scheme adopted by the invention is as follows:
For the composition of jasmine tea halogen, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient includes dark green tea 40-
60 parts, 40-60 parts of green tea, 40-60 parts of jasmine tea, 40-60 parts of osmanthus flower tea, 40-60 parts of tartary buckwheat tea, spun gold emperor's chrysanthemum tea 40-60
Part, 20-40 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, 20-40 parts of Siraitia grosvenorii, Radix Glycyrrhizae
20-40 parts, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali, 20-40 parts of the sterculia seed and Radix Ophiopogonis 90-110 part；
Adjuvant includes 40-60 parts of black tea, green 40-60 parts of tea, 40-60 parts of yellow tea, 40-60 parts of white tea, magnolia tea 40-60
Part, 40-60 parts of lily tea, 40-60 parts of mint-leaf tea, 40-60 parts of mulberry leaf, 40-60 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 10-30 parts, 40-60 parts of amaranth reality, 20-40 parts of cassia seed, 40-60 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
Tea polyphenols, Tea Pigment, theanine, tea polysaccharide and Υ-aminobutyric acid are contained in tealeaves mostly, heart and brain blood can be lowered
Pipe morbidity and mortality risk；Play the role of reducing cholesterol and blood pressure；Help to reduce the risk for suffering from diabetes；Help to prevent and treat
Alzheimer's disease；There are compressive resistance and angst resistance effect；Immunity can be improved；7) sterilizing power can be improved；There is weight-reducing effect；Also
Fatigue can be eliminated, refreshes oneself, improving eyesight, help digestion, diuresis removing toxic substances, prevent saprodontia, eliminate halitosis, tea or alkaline drink, is conducive to acid
The correction and other effects of property constitution.
Cooperate remaining component, this is made to reach moistening lung, preventing phlegm from forming and stopping coughing, liver protection nourishing the stomach, diuresis row for the composition of jasmine tea halogen
Poison, softening blood vessel and other effects.
Preferably, the composition for jasmine tea halogen, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 45-55 parts of dark green tea, 45-55 parts of green tea, 45-55 parts of jasmine tea, 45-55 parts of osmanthus flower tea, 45-55 parts of tartary buckwheat tea, spun gold
45-55 parts of emperor's chrysanthemum tea, 25-35 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, Siraitia grosvenorii
20-40 parts, 20-40 parts of Radix Glycyrrhizae, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali, 20-40 parts of the sterculia seed and Radix Ophiopogonis
90-110 parts；
Adjuvant includes 45-55 parts of black tea, green 45-55 parts of tea, 45-55 parts of yellow tea, 45-55 parts of white tea, magnolia tea 45-55
Part, 45-55 parts of lily tea, 45-55 parts of mint-leaf tea, 40-60 parts of mulberry leaf, 40-60 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 10-30 parts, 40-60 parts of amaranth reality, 20-40 parts of cassia seed, 40-60 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
By reducing the content range of teas component, the influence of the substances to human body such as caffeine, tea polyphenols in reduction tealeaves,
Reduce the range of not applicable crowd.
Preferably, the composition for jasmine tea halogen, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 45-55 parts of dark green tea, 45-55 parts of green tea, 45-55 parts of jasmine tea, 45-55 parts of osmanthus flower tea, 45-55 parts of tartary buckwheat tea, spun gold
45-55 parts of emperor's chrysanthemum tea, 25-35 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, Siraitia grosvenorii
25-35 parts, 20-40 parts of Radix Glycyrrhizae, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali, 25-35 parts of the sterculia seed and Radix Ophiopogonis
95-105 parts；
Adjuvant includes 45-55 parts of black tea, green 45-55 parts of tea, 45-55 parts of yellow tea, 45-55 parts of white tea, magnolia tea 45-55
Part, 45-55 parts of lily tea, 45-55 parts of mint-leaf tea, 45-55 parts of mulberry leaf, 45-55 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 10-30 parts, 40-60 parts of amaranth reality, 25-35 parts of cassia seed, 40-60 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
By reduction Siraitia grosvenorii, the sterculia seed, Radix Ophiopogonis, mulberry leaf, cape jasmine and cassia seed content range, these components all for
Deficiency-cold in spleen and stomach, the user to suffer from indiestion are unfriendly, and the range for reducing these components keeps its performance effect more acurrate, are conducive to root
This composition for jasmine tea halogen is adjusted according to user's own situation.
Preferably, the composition for jasmine tea halogen, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 45-55 parts of dark green tea, 45-55 parts of green tea, 45-55 parts of jasmine tea, 45-55 parts of osmanthus flower tea, 45-55 parts of tartary buckwheat tea, spun gold
45-55 parts of emperor's chrysanthemum tea, 25-35 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, Siraitia grosvenorii
25-35 parts, 25-35 parts of Radix Glycyrrhizae, 20-40 parts of fig, 45-55 parts of dried orange peel, 25-35 parts of Radix Astragali, 25-35 parts of the sterculia seed and Radix Ophiopogonis
95-105 parts；
Adjuvant includes 45-55 parts of black tea, green 45-55 parts of tea, 45-55 parts of yellow tea, 45-55 parts of white tea, magnolia tea 45-55
Part, 45-55 parts of lily tea, 45-55 parts of mint-leaf tea, 45-55 parts of mulberry leaf, 45-55 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 15-25 parts, 45-55 parts of amaranth reality, 25-35 parts of cassia seed, 45-55 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
Reduced by the content range of reduction Radix Glycyrrhizae, dried orange peel, Radix Astragali, Radix Angelicae Sinensis, amaranth reality and Radix Codonopsis, Radix Glycyrrhizae, Radix Codonopsis are not
Preferably largely take, dried orange peel, Radix Angelicae Sinensis and amaranth are not all suitable for the user to suffer from indiestion in fact, Radix Astragali also have avoid physical condition it is bad when
It uses, the range by reducing these components keeps its performance effect more acurrate, is conducive to according to user's own situation to this use
It is adjusted in the composition of jasmine tea halogen.
Preferably, the composition for jasmine tea halogen, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 45-55 parts of dark green tea, 45-55 parts of green tea, 45-55 parts of jasmine tea, 45-55 parts of osmanthus flower tea, 45-55 parts of tartary buckwheat tea, spun gold
45-55 parts of emperor's chrysanthemum tea, 25-35 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, Siraitia grosvenorii
25-35 parts, 25-35 parts of Radix Glycyrrhizae, 20-40 parts of fig, 45-55 parts of dried orange peel, 25-35 parts of Radix Astragali, 25-35 parts of the sterculia seed and Radix Ophiopogonis
95-105 parts；
Adjuvant includes 45-55 parts of black tea, green 45-55 parts of tea, 45-55 parts of yellow tea, 45-55 parts of white tea, magnolia tea 45-55
Part, 45-55 parts of lily tea, 45-55 parts of mint-leaf tea, 45-55 parts of mulberry leaf, 45-55 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 15-25 parts, 45-55 parts of amaranth reality, 25-35 parts of cassia seed, 45-55 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=2:1.
By determining main ingredient: adjuvant takes determining value, determines main ingredient and adjuvant optimum mixture ratio example, keeps main ingredient and adjuvant mutual
It is more preferable to play effect for cooperation.
Preferably, the composition for jasmine tea halogen, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 50 parts of dark green tea, 50 parts of green tea, 50 parts of jasmine tea, 50 parts of osmanthus flower tea, 50 parts of tartary buckwheat tea, 50 parts of spun gold emperor chrysanthemum tea, gold and silver
50 parts of jasmine tea, 50 parts of roselle, 50 parts of lycium ruthenicum, 50 parts of jujube, 30 parts of Siraitia grosvenorii, 30 parts of Radix Glycyrrhizae, 30 parts of fig, dried orange peel 50
Part, 30 parts of Radix Astragali, 30 parts of the sterculia seed and 100 parts of Radix Ophiopogonis；
50 parts of black tea, green 50 parts of tea, 50 parts of yellow tea, 50 parts of white tea, 50 parts of magnolia tea, 50 parts of lily tea, dried peppermint leaf
50 parts of tea, 50 parts of mulberry leaf, 50 parts of cape jasmine, 30 parts of red fructus lycii, 20 parts of Radix Angelicae Sinensis, 50 parts of amaranth reality, 30 parts of cassia seed, 50 parts of Radix Codonopsis and medicine
50 parts of osmanthus；
In use, main ingredient: adjuvant=2:1.
By determining each component and main ingredient: the value of adjuvant makes each component combine, and plays best effect.
The production method of composition for jasmine tea halogen, comprising the following steps:
S101: it takes and prepares raw material for any proportion in the composition of jasmine tea halogen described in claim 1-6；
S102: it is put into being packed after main ingredient cleaning in slaughterhouse, being stewed slowly with small fire makes the pharmacological property of the main ingredient penetrate into soup
In；
S103: it is put into being packed after adjuvant cleaning in slaughterhouse, being stewed slowly with small fire makes the pharmacological property of the adjuvant penetrate into soup
In；
S104: after the head soup that the main ingredient stews the head soup of system and the adjuvant stews system is outwelled, by the main ingredient of pack and
The adjuvant of pack is put into the same slaughterhouse and is stewed slowly with small fire；
S105: pot takes out the main ingredient and the adjuvant after making.
Preferably, the cleaning of the main ingredient and the adjuvant is after clear water is cleaned, to make after impregnating 10min with warm water
With.
Keep each component cleaner by the secondary cleaning of clear water, warm water, it is less into the impurity in soup, it is more strong to human body
Health.
Preferably, the small fire is 98-110 DEG C, and slow stew is infusion 50-70min.
Small fire stews slowly guarantees that the various beneficiating ingredients in raw material can be dissolved in soup, at the same make the fibr tissue of raw material not by
Damage, keeps the body of raw material complete, soup look can also be made to clarify, alcohol is just delicious.
The invention has the benefit that
This for jasmine tea halogen composition by the organic assembling of each component, reached moistening lung, preventing phlegm from forming and stopping coughing, liver protection are supported
Stomach, diuresis toxin expelling, softening blood vessel and other effects, while can rationally increase or reduce according to the actual body situation of user
Main ingredient: the ratio of adjuvant increases the ratio for facilitating the component of user on the basis of retaining existing effect, reduces harm
The ratio of the component of user makes this more be bonded the physical condition of user for the composition of jasmine tea halogen；
Detailed description of the invention
Fig. 1 is this flow diagram for the production method of the composition of jasmine tea halogen.
Specific embodiment
With reference to the accompanying drawing and specific embodiment the present invention is further elaborated.
Embodiment one:
The composition for jasmine tea halogen of the present embodiment, raw material raw material in parts by weight, including main ingredient and adjuvant, wherein
Main ingredient include 40-60 parts of dark green tea, 40-60 parts of green tea, 40-60 parts of jasmine tea, 40-60 parts of osmanthus flower tea, 40-60 parts of tartary buckwheat tea,
40-60 parts of spun gold emperor's chrysanthemum tea, 20-40 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, sieve
20-40 parts of Chinese fruit, 20-40 parts of Radix Glycyrrhizae, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali, 20-40 parts of the sterculia seed and
Radix Ophiopogonis 90-110 part；
Adjuvant includes 40-60 parts of black tea, green 40-60 parts of tea, 40-60 parts of yellow tea, 40-60 parts of white tea, magnolia tea 40-60
Part, 40-60 parts of lily tea, 40-60 parts of mint-leaf tea, 40-60 parts of mulberry leaf, 40-60 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 10-30 parts, 40-60 parts of amaranth reality, 20-40 parts of cassia seed, 40-60 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
This composition no matter in main ingredient or adjuvant for jasmine tea halogen, all contains a variety of tealeaves, wraps mostly in tealeaves
Tea polyphenols, Tea Pigment, theanine, tea polysaccharide and Υ-aminobutyric acid are contained, for expansion, tea polyphenols are that content is most in tealeaves
A kind of soluble component and tealeaves play the most important substance of its health care effect, most typical representative is catechin
(phenol) has anti-oxidant (eliminating oxygen radical), anti-inflammatory, reduction cardiovascular disease incidence probability, pre- anti-cancer, reducing blood lipid, reduction
Body fat formation, changes the multinomial effects such as intestinal flora ecology at antibacterial；Tea Pigment mainly includes chlorophyll, beta carotene etc., tool
There is the effects of anti-cancer, anti-aging and beauty；Theanine can improve cerebral function, enhance memory and learning ability, right
Alzheimer disease (senile dementia), Parkinson's disease and autonomic nervous dysfunction have prevention effect；Tea polysaccharide be it is a kind of at
Divide complicated mixture.Tea polysaccharide has the function of anti-radiation, increase quantity of leucocyte, raising immunity, moreover it is possible to hypoglycemic.The people
Between spread bubble and drink the practice that thick tea controls diabetes, be mainly exactly the effect for having played tea polysaccharide；Υ-aminobutyric acid is in natural tea
Middle content is few, but its processed rear content of tealeaves is significantly increased, and Υ-aminobutyric acid primary efficacy is that expansion blood vessel makes blood pressure
Decline, therefore can assisting in treating hypertension；It can also improve cerebral blood circulation, enhance the metabolic capability of brain cell, this facilitates
The rehabilitation of cerebral apoplexy (apoplexy), cerebral arteriovenous malformation sequelae etc..
In brief, tealeaves has following health-care effect due to the presence of mentioned component: 1) can lower cardiovascular and cerebrovascular morbidity
And mortality risk；2) play the role of reducing cholesterol and blood pressure；3) facilitate to reduce the risk for suffering from diabetes；4) facilitate to prevent and treat
Alzheimer's disease；5) there are compressive resistance and angst resistance effect；6) immunity can be improved；7) sterilizing power can be improved；8) there is weight-reducing
Effect；9) fatigue can also be eliminated, refreshes oneself, improving eyesight, help digestion, diuresis removing toxic substances, prevent saprodontia, eliminate halitosis, tea or alkaline drink,
Be conducive to the correction and other effects of acidic constitution.
Certainly, particular problem is made a concrete analysis of, and different types of tealeaves is further comprised each due to the difference of natural environmental condition
From exclusive ingredient, and then also there is unique beneficial effect on the basis of tealeaves shares health-care effect, specifically, main
In medicine, dark green tea nutriment is abundant, contains multivitamin and minerals；The tea polyphenols of green tea and the content of caffeine are high,
Facilitate arousing brain, raising spirit, diuresis is recovered from fatigue, the effects of relieving fatigue, protect tooth improving eyesight and anti-aging；Volatile oil contained by jasmine tea
Property substance, there is promoting qi circulation and relieving pain, the symptom such as the effect of relieve stagnation dissipating bind can be relieved chest and abdomen swelling and pain, and diarrhea is tenesmus, contained waves
Oily matter is sent out, there is promoting qi circulation and relieving pain, the symptom such as the effect of relieve stagnation dissipating bind can be relieved chest and abdomen swelling and pain, and diarrhea is tenesmus；Sweet osmanthus
Tea warmly nourishing Yangqi skin whitening, mediates vivotoxin, is relieving cough and reducing sputum, health moistening lung；In tartary buckwheat tea containing rutin, microelement,
Flavonoid substance and oleic acid, linoleic acid, rutin can mitigate the pathologic, physiologic damage to acute pancreatitis, and magnesium can reduce in microelement
Serum cholesterol, selenium can promote insulin secretion to increase direct scavenging activated oxygen, and insulin function can be enhanced in chromium, improve Portugal
Grape sugar tolerance etc., oleic acid, linoleic acid can promote physical growth of children to develop；Afyon chrysanthemum tea, that is, chrysanthemum tea, have clearing liver nourishing the liver,
The effect of spirit refreshing and eye-brightening, while increasing capillary, cardiovascular resistance；Honeysuckle tea has resisting pathogenic microbes, cool blood
The effects of stop dysentery, eliminating inflammation and expelling toxin and sterilization；Rose tea
In adjuvant, black tea is rich in carrotene, vitamin A, calcium, phosphorus, magnesium, potassium, caffeine, isoleucine, leucine, relies
The various nutrient elements such as propylhomoserin, glutamic acid, alanine, asparatate are to eliminate oedema, and strong cardiac function, in black tea
Tea polybase can adsorb heavy metal and alkaloid, and precipitate decomposition；Containing organic chemical composition up to more than 450 kinds in green tea, nothing
Machine mineral element is up to more than 40 kinds, and the organic chemical composition and inorganic mineral element in tealeaves are containing there are many nutritional ingredient and drug effects
Ingredient, skin allergy can be improved more by drinking green tea, and the middle-aged and the old often drinks and helps to maintain hearing；Yellow tea is to macerate tea, in the mistake macerated
Cheng Zhong can generate a large amount of digestive ferment, and, indigestion most beneficial to taste, loss of appetite, lazy move is fat, can all drink and change
It, while natural materials remain with 85% or more in yellow tea fresh leaf, and these substances have spy to anti-cancer, anticancer, sterilization, anti-inflammatory
Special effect fruit；The drug effect performance of white tea is fine, has Dealcoholic sobering-up, clearing heat and moistening lung, calming the liver benefit blood, eliminating inflammation and expelling toxin, decompression fat reducing, disappears
Except fatigue and other effects, especially for excessively prosperous caused uncomfortable, digestive functional disturbance of excessive drinking and smoking, greasy excessive, irascibility etc.
Disease has unique, ethereality health-care effect, and also containing organized enzyme necessary to human body, long-term drinking white tea can be significantly improved
Internal lipase (lipoproteinlipase) activity promotes catabolism of fat, effectively control amount of insulin secretion, delays Portugal
The intestinal absorption of grape powder, the extra sugar of blood in decomposer promote blood glucose balance, while the flavonoids natural goods such as dihydromyricetin
Matter can protect liver, and accelerating alcohol metabolism product acetaldehyde decomposes rapidly, become innocuous substance, reduce the damage to liver cell；
Magnolia tea fragrance is fresh dense lasting, and flavour is mellow, and soup look Huang is bright；There is the effect of gentle, dissolving phlegm, beneficial lung；Lily tea moistening lung
Cough-relieving, antitoxic heart-soothing and sedative, moreover it is possible to which mitigation has a stomach-ache；Nuciferine in mint-leaf tea can neutralize greasy ingredient, can also stop blooding, solve
Hot, antibacterial, spasmolysis effect；There is kidney strengthening the essence in medicine osmanthus, protects liver, and hypertension and hyperlipemia enhances human immunity, and defaecation diuresis is prolonged
The effect of slow aging, beautifying face and moistering lotion.
This is for remaining component in the composition of jasmine tea halogen, and in main ingredient, lycium ruthenicum vitamin and fat content are high, iron,
Calcium, magnesium, zinc, the content of copper are high, while the blue and white element of original rich in anti-aging；Jujube contains protein, carbohydrate, organic acid, dimension life
The nutritions abundant such as plain A, vitamin C, lot of trace calcium and amino acid, rutin contained by jujube, can make angiomalasia, from
And reduce blood pressure, there is prophylactic-therapeutic effect to high blood pressure, enhancing muscular strength eliminates fatigue, expansion blood vessel, increases myocardial contractive power, changes
The effects of mercy myotrophy；Siraitia grosvenorii is sweet in flavor cool in nature, and return lung, large intestine channel have the effect of moistening lung to arrest cough, promote the production of body fluid to quench thirst, are suitable for
The effect of lung heat or xeropulmonary cough, pertussis and hot summer weather fluid deficiency and thirst etc., in addition there are relax bowel and defecation；Fig invigorating stomach and promoting bower movements,
Subdhing swelling and detoxicating controls enteritis, dysentery, constipation, hemorrhoid, laryngalgia, ulcerative carbuncle scabies, throat, expelling parasite of whetting the appetite；Dried orange peel is the drying of plant
Mature pericarp, it is bitter, pungent, it is warm-natured, there is regulating qi-flowing for strengthening spleen, eliminating dampness and eliminating phlegm effect is mainly used for regulating qi-flowing for strengthening spleen, eliminating dampness and eliminating phlegm equal diseases
Shape；Radix Astragali has enhancing body's immunity, liver protection, diuresis, anti-aging, resisting stress, decompression and wide antibacterial action, can disappear
Except experimental nephritis proteinuria, enhance myocardial contractive power, adjust blood-sugar content, can not only coronary artery dilator, improve cardiac muscle and supply
Blood improves immune function, and is capable of the process of delaying cell aging；Sterculia seed taste is sweet cold in nature, and light surname dissipate above enters lung channel
Clear promoting the dispersing function of the lung gas is larynx section good medicine；Under return large intestine channel gut purge defaecation, with controlling fire toxin disease in top caused by constipation with heat retention, because the efficacy of a drug compared with
It is weak, it is only applicable to mild；Radix Ophiopogonis mainly contains dwarf lilyturf glycosides, steroid saponin, alkaloid, sitosterol, glucose, amino acid, dimension life
Element etc., have the function of it is antifatigue, remove free radical, improve cellular immune function and hypoglycemic, there are also promote islet cells
Functional rehabilitation, the effect for increasing hepatic glycogen, reducing blood glucose are the regular supplies in sugared friendly prescription.
In adjuvant, mulberry leaf have the function of anticoagulation, blood pressure lowering, hypoglycemic, reducing blood lipid, antibacterial anti-inflammatory, also have anti-ageing
Always, the effects of antifatigue, spasmolysis and antiulcer；Cape jasmine purging intense heat relieving restlessness clearing heat and promoting diuresis, is clear liver and improved vision, swelling and pain relieving；Red fructus lycii has
Improve the effect of immunity of organisms, it is smart by force to play tonifying Qi, nourishing liver and kidney, only quench one's thirst, improve sleep, is warming up body, antitumor
Effect；Radix Angelicae Sinensis being capable of relax bowel and defecation, activating microcirculation and removing stasis medicinal, menstruction regulating and pain relieving；Amaranth in fact is used as medicine with seed, it is sweet in flavor, it is cold in nature, can heat-clearing it is bright
Mesh, smoothening secretion；Cassia seed is used as medicine with dry mature seed, sweet in flavor, bitter, cold in nature, micro- salty, can relax bowel and defecation, lipid-loweringing, clearly
Liver, improving eyesight, sharp water defaecation, reducing blood pressure and blood fat are usually used in treating constipation and hyperlipidemia, hypertension；Radix Codonopsis can it is calm it is antipyretic,
Blood pressure lowering, it is hypoglycemic, increase hematopoiesis function, liver protection antidiuresis the effects of；Medicine osmanthus
Certainly, there's no such thing as a totally safe medicine, this each component for being used for the composition of jasmine tea halogen also do certain harm or taboo: tea
Caffeine in leaf is secreted gastric juice by stimulating intestine and stomach to help human consumption, but is just exacerbated for patients with peptic ulcer
Ulcer；Caffeine has excitation to human central nervous system, is unfavorable for neurasthenia or insomniac；Meanwhile caffeine, tea
Alkali, theobromine etc. can accelerate corticocerebral excitability, cause cerebral vasoconstriction, blood supply insufficiency, Hemodynamic environment slow, promote brain
Thrombus occurs；Catechu polyphenols has certain astriction to stomach class mucous membrane, thus affects the digestion to food
Absorption function makes dry and hard excrement, causes constipation or exacerbation；Tealeaves too high levels can aggravate heart burden, make increased heart rate, blood pressure
It increases；Tannic acid can form a large amount of sediments in conjunction with the iron molecule in food, interfere absorption of the intestinal mucosa to iron molecule；It is raw
Alkaloids substance can inhibit duodenum to calcareous absorption, while can also promote the discharge of calcium in urine, make human body it is calcareous it is few into
It has more, leads to calcium deficiency and osteoporosis, fracture is made to be difficult to rehabilitation；Women is also unsuitable for using this in menstrual period or pregnancy period for spending
The composition of tea halogen.
This is used for remaining ingredient of the composition of jasmine tea halogen, such as Siraitia grosvenorii too sweet tea, is easy the impairment of the spleen, long-term drinking will lead to
The decline of gastrointestinal function；Long-term drinking will lead to the decline of gastrointestinal function, while long-term drinking will lead to the decline of gastrointestinal function；
Fig is cool in nature, for suffering from indiestion, is easy diarrhea or the thin person in big loose stool, inedibility fig；Hyperhydrochloria, medication period
Between or pregnant woman be unsuitable for eating dried orange peel；Radix Astragali is not suitable for nephrotic, and female menstrual period or pregnancy period need to be used with caution；The sterculia seed
Be not suitable for spleen-stomach deficiency-cold type diarrhea person, diabetic and hypotensive；Radix Ophiopogonis is cool in nature, and deficiency-cold in spleen and stomach diarrhea, stomach has phlegm retention
Wet turbid and sudden and violent sense cough due to wind-cold evil person avoids clothes；Mulberry leaf are that spleen deficiency loose stool person avoids clothes；Manchu group takes Radix Angelicae Sinensis with caution in dampness, defecates
Loose stool crowd takes Radix Angelicae Sinensis with caution, must not also take Radix Angelicae Sinensis before postpartum tire；The sliding person of rushing down of stool avoids use to amaranth in fact, avoids especially and soft-shelled turtle is the same as food；.
Radix Codonopsis anti-black false hellebore, Radix Codonopsis and black false hellebore cannot be with use, while pareordia discomfort probably occurs in dosage excessive (every dose more than 60g)
Sense and cardiac arrhythmia, symptom can be self-healing after drug withdrawal.
In conclusion this is used for the composition of jasmine tea halogen by the organic assembling of each component, moistening lung is reached, resolving sputum stops
Cough, liver protection nourishing the stomach, diuresis toxin expelling, softening blood vessel and other effects, while can rationally be increased according to the actual body situation of user
Or main ingredient: the ratio of adjuvant is reduced, on the basis of retaining existing effect, increase the ratio for facilitating the component of user,
The ratio for endangering the component of user is reduced, this is made more to be bonded the physical condition of user for the composition of jasmine tea halogen.
This composition for being used for jasmine tea halogen is used with caution for pregnant woman, the person of having a stomach upset, easy diarrhea person.
Embodiment two:
The present embodiment relative to embodiment one the difference is that: will be each in the composition for being used for jasmine tea halogen
The content of component gets the small value.
The composition for jasmine tea halogen of the present embodiment, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 40 parts of dark green tea, 40 parts of green tea, 40 parts of jasmine tea, 40 parts of osmanthus flower tea, 40 parts of tartary buckwheat tea, 40 parts of spun gold emperor chrysanthemum tea, gold and silver
20 parts of jasmine tea, 40 parts of roselle, 40 parts of lycium ruthenicum, 40 parts of jujube, 20 parts of Siraitia grosvenorii, 20 parts of Radix Glycyrrhizae, 20 parts of fig, dried orange peel 40
Part, 20 parts of Radix Astragali, 20 parts of the sterculia seed and 90 parts of Radix Ophiopogonis；
Adjuvant includes 40 parts of black tea, green 40 parts of tea, 40 parts of yellow tea, 40 parts of white tea, 40 parts of magnolia tea, lily tea 40
Part, 40 parts of mint-leaf tea, 40 parts of mulberry leaf, 40 parts of cape jasmine, 20 parts of red fructus lycii, 10 parts of Radix Angelicae Sinensis, amaranth real 40 parts, 20 parts of cassia seed, party
40 parts of 40 parts of ginseng and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
Embodiment three:
The present embodiment relative to embodiment one the difference is that: will be each in the composition for being used for jasmine tea halogen
The content of component takes large values.
The composition for jasmine tea halogen of the present embodiment, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 60 parts of dark green tea, 60 parts of green tea, 60 parts of jasmine tea, 60 parts of osmanthus flower tea, 60 parts of tartary buckwheat tea, 60 parts of spun gold emperor chrysanthemum tea, gold and silver
40 parts of jasmine tea, 60 parts of roselle, 60 parts of lycium ruthenicum, 60 parts of jujube, 40 parts of Siraitia grosvenorii, 40 parts of Radix Glycyrrhizae, 40 parts of fig, dried orange peel 60
Part, 40 parts of Radix Astragali, 40 parts of the sterculia seed and 110 parts of Radix Ophiopogonis；
Adjuvant includes 60 parts of black tea, green 60 parts of tea, 60 parts of yellow tea, 60 parts of white tea, 60 parts of magnolia tea, lily tea 60
Part, 60 parts of mint-leaf tea, 60 parts of mulberry leaf, 60 parts of cape jasmine, 40 parts of red fructus lycii, 30 parts of Radix Angelicae Sinensis, amaranth real 60 parts, 40 parts of cassia seed, party
60 parts of 60 parts of ginseng and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
Example IV:
The present embodiment relative to embodiment one the difference is that: will be each in the composition for being used for jasmine tea halogen
The median containing measurement of component.
The composition for jasmine tea halogen of the present embodiment, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 50 parts of dark green tea, 50 parts of green tea, 50 parts of jasmine tea, 50 parts of osmanthus flower tea, 50 parts of tartary buckwheat tea, 50 parts of spun gold emperor chrysanthemum tea, gold and silver
50 parts of jasmine tea, 50 parts of roselle, 50 parts of lycium ruthenicum, 50 parts of jujube, 30 parts of Siraitia grosvenorii, 30 parts of Radix Glycyrrhizae, 30 parts of fig, dried orange peel 50
Part, 30 parts of Radix Astragali, 30 parts of the sterculia seed and 100 parts of Radix Ophiopogonis；
50 parts of black tea, green 50 parts of tea, 50 parts of yellow tea, 50 parts of white tea, 50 parts of magnolia tea, 50 parts of lily tea, dried peppermint leaf
50 parts of tea, 50 parts of mulberry leaf, 50 parts of cape jasmine, 30 parts of red fructus lycii, 20 parts of Radix Angelicae Sinensis, 50 parts of amaranth reality, 30 parts of cassia seed, 50 parts of Radix Codonopsis and medicine
50 parts of osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
Embodiment five:
The present embodiment and embodiment one the difference is that: by the main ingredient in the composition for being used for jasmine tea halogen: auxiliary
Medicine is minimized.
The composition for jasmine tea halogen of the present embodiment, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 40-60 parts of dark green tea, 40-60 parts of green tea, 40-60 parts of jasmine tea, 40-60 parts of osmanthus flower tea, 40-60 parts of tartary buckwheat tea, spun gold
40-60 parts of emperor's chrysanthemum tea, 20-40 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, Siraitia grosvenorii
20-40 parts, 20-40 parts of Radix Glycyrrhizae, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali, 20-40 parts of the sterculia seed and Radix Ophiopogonis
90-110 parts；
Adjuvant includes 40-60 parts of black tea, green 40-60 parts of tea, 40-60 parts of yellow tea, 40-60 parts of white tea, magnolia tea 40-60
Part, 40-60 parts of lily tea, 40-60 parts of mint-leaf tea, 40-60 parts of mulberry leaf, 40-60 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 10-30 parts, 40-60 parts of amaranth reality, 20-40 parts of cassia seed, 40-60 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1.
Embodiment six:
The present embodiment and embodiment one the difference is that: by the main ingredient in the composition for being used for jasmine tea halogen: auxiliary
Medicine is maximized.
The composition for jasmine tea halogen of the present embodiment, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 40-60 parts of dark green tea, 40-60 parts of green tea, 40-60 parts of jasmine tea, 40-60 parts of osmanthus flower tea, 40-60 parts of tartary buckwheat tea, spun gold
40-60 parts of emperor's chrysanthemum tea, 20-40 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, Siraitia grosvenorii
20-40 parts, 20-40 parts of Radix Glycyrrhizae, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali, 20-40 parts of the sterculia seed and Radix Ophiopogonis
90-110 parts；
Adjuvant includes 40-60 parts of black tea, green 40-60 parts of tea, 40-60 parts of yellow tea, 40-60 parts of white tea, magnolia tea 40-60
Part, 40-60 parts of lily tea, 40-60 parts of mint-leaf tea, 40-60 parts of mulberry leaf, 40-60 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 10-30 parts, 40-60 parts of amaranth reality, 20-40 parts of cassia seed, 40-60 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=2.5:1.
Embodiment seven:
The present embodiment and embodiment one the difference is that: by the main ingredient in the composition for being used for jasmine tea halogen: auxiliary
Medicine takes median.
The composition for jasmine tea halogen of the present embodiment, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 40-60 parts of dark green tea, 40-60 parts of green tea, 40-60 parts of jasmine tea, 40-60 parts of osmanthus flower tea, 40-60 parts of tartary buckwheat tea, spun gold
40-60 parts of emperor's chrysanthemum tea, 20-40 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, Siraitia grosvenorii
20-40 parts, 20-40 parts of Radix Glycyrrhizae, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali, 20-40 parts of the sterculia seed and Radix Ophiopogonis
90-110 parts；
Adjuvant includes 40-60 parts of black tea, green 40-60 parts of tea, 40-60 parts of yellow tea, 40-60 parts of white tea, magnolia tea 40-60
Part, 40-60 parts of lily tea, 40-60 parts of mint-leaf tea, 40-60 parts of mulberry leaf, 40-60 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 10-30 parts, 40-60 parts of amaranth reality, 20-40 parts of cassia seed, 40-60 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=2:1.
Embodiment eight:
The present embodiment and embodiment one the difference is that: by the tealeaves class group in the composition for being used for jasmine tea halogen
Divide, such as dark green tea, green tea, jasmine tea, the range of content are reduced.
The composition for jasmine tea halogen of the present embodiment, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 45-55 parts of dark green tea, 45-55 parts of green tea, 45-55 parts of jasmine tea, 45-55 parts of osmanthus flower tea, 45-55 parts of tartary buckwheat tea, spun gold
45-55 parts of emperor's chrysanthemum tea, 25-35 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, Siraitia grosvenorii
20-40 parts, 20-40 parts of Radix Glycyrrhizae, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali, 20-40 parts of the sterculia seed and Radix Ophiopogonis
90-110 parts；
Adjuvant includes 45-55 parts of black tea, green 45-55 parts of tea, 45-55 parts of yellow tea, 45-55 parts of white tea, magnolia tea 45-55
Part, 45-55 parts of lily tea, 45-55 parts of mint-leaf tea, 40-60 parts of mulberry leaf, 40-60 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 10-30 parts, 40-60 parts of amaranth reality, 20-40 parts of cassia seed, 40-60 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
In the present embodiment, this is changed for teas component in the composition of jasmine tea halogen, such as dark green tea, green tea, Jasmine
The range of tea etc., content is reduced, and keeps the content of each component more accurate, by reducing the content range of teas component,
Reduce the influence of the substances to human body such as caffeine, tea polyphenols in tealeaves, reduces the range of not applicable crowd.
Embodiment nine:
The present embodiment and embodiment eight the difference is that: by the jasmine tea halogen that is used on the basis of embodiment eight
The content range of Siraitia grosvenorii, the sterculia seed, Radix Ophiopogonis, mulberry leaf, cape jasmine and cassia seed in composition is reduced.
The composition for jasmine tea halogen of the present embodiment, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 45-55 parts of dark green tea, 45-55 parts of green tea, 45-55 parts of jasmine tea, 45-55 parts of osmanthus flower tea, 45-55 parts of tartary buckwheat tea, spun gold
45-55 parts of emperor's chrysanthemum tea, 25-35 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, Siraitia grosvenorii
25-35 parts, 20-40 parts of Radix Glycyrrhizae, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali, 25-35 parts of the sterculia seed and Radix Ophiopogonis
95-105 parts；
Adjuvant includes 45-55 parts of black tea, green 45-55 parts of tea, 45-55 parts of yellow tea, 45-55 parts of white tea, magnolia tea 45-55
Part, 45-55 parts of lily tea, 45-55 parts of mint-leaf tea, 45-55 parts of mulberry leaf, 45-55 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 10-30 parts, 40-60 parts of amaranth reality, 25-35 parts of cassia seed, 40-60 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
In the present embodiment, this is changed for Siraitia grosvenorii, the sterculia seed, Radix Ophiopogonis, mulberry leaf, cape jasmine in the composition of jasmine tea halogen
Reduced with the content range of cassia seed, keep the content of each component more accurate, by reduction Siraitia grosvenorii, the sterculia seed, Radix Ophiopogonis,
Mulberry leaf, cape jasmine and cassia seed content range, these components are all unfriendly for deficiency-cold in spleen and stomach, the user to suffer from indiestion, contracting
The range for subtracting these components keeps its performance effect more acurrate, is conducive to the group for being used for jasmine tea halogen to this according to user's own situation
Object is closed to be adjusted.
Embodiment ten:
The present embodiment and embodiment nine the difference is that: by the Radix Glycyrrhizae, old in the composition for being used for jasmine tea halogen
Skin, Radix Astragali, Radix Angelicae Sinensis, amaranth reality and Radix Codonopsis content range reduced.
The composition for jasmine tea halogen of the present embodiment, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 45-55 parts of dark green tea, 45-55 parts of green tea, 45-55 parts of jasmine tea, 45-55 parts of osmanthus flower tea, 45-55 parts of tartary buckwheat tea, spun gold
45-55 parts of emperor's chrysanthemum tea, 25-35 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, Siraitia grosvenorii
25-35 parts, 25-35 parts of Radix Glycyrrhizae, 20-40 parts of fig, 45-55 parts of dried orange peel, 25-35 parts of Radix Astragali, 25-35 parts of the sterculia seed and Radix Ophiopogonis
95-105 parts；
Adjuvant includes 45-55 parts of black tea, green 45-55 parts of tea, 45-55 parts of yellow tea, 45-55 parts of white tea, magnolia tea 45-55
Part, 45-55 parts of lily tea, 45-55 parts of mint-leaf tea, 45-55 parts of mulberry leaf, 45-55 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 15-25 parts, 45-55 parts of amaranth reality, 25-35 parts of cassia seed, 45-55 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
In the present embodiment, change this Radix Glycyrrhizae, dried orange peel, Radix Astragali, Radix Angelicae Sinensis, amaranth in the composition of jasmine tea halogen it is real and
The content range of Radix Codonopsis is reduced, and keeps the content of each component more accurate, by reducing Radix Glycyrrhizae, dried orange peel, Radix Astragali, Radix Angelicae Sinensis, amaranth
Real and Radix Codonopsis content range is reduced, and Radix Glycyrrhizae, Radix Codonopsis should not largely be taken, and dried orange peel, Radix Angelicae Sinensis and amaranth are not all suitable for intestines in fact
The bad user of stomach, Radix Astragali also have avoid physical condition it is bad when use, the range by reducing these components make its play function
It imitates more acurrate, is conducive to be adjusted this for composition of jasmine tea halogen according to user's own situation.
Embodiment 11:
The present embodiment and embodiment ten the difference is that: by the main ingredient in the composition for being used for jasmine tea halogen: auxiliary
Medicine takes determining value.
The composition for jasmine tea halogen of the present embodiment, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 45-55 parts of dark green tea, 45-55 parts of green tea, 45-55 parts of jasmine tea, 45-55 parts of osmanthus flower tea, 45-55 parts of tartary buckwheat tea, spun gold
45-55 parts of emperor's chrysanthemum tea, 25-35 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, Siraitia grosvenorii
25-35 parts, 25-35 parts of Radix Glycyrrhizae, 20-40 parts of fig, 45-55 parts of dried orange peel, 25-35 parts of Radix Astragali, 25-35 parts of the sterculia seed and Radix Ophiopogonis
95-105 parts；
Adjuvant includes 45-55 parts of black tea, green 45-55 parts of tea, 45-55 parts of yellow tea, 45-55 parts of white tea, magnolia tea 45-55
Part, 45-55 parts of lily tea, 45-55 parts of mint-leaf tea, 45-55 parts of mulberry leaf, 45-55 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis
40-60 parts of 15-25 parts, 45-55 parts of amaranth reality, 25-35 parts of cassia seed, 45-55 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=2:1.
In the present embodiment, the main ingredient in the composition for jasmine tea halogen: adjuvant takes determining value, makes main ingredient: adjuvant
More accurate, by determining main ingredient: adjuvant takes determining value, determines main ingredient and adjuvant optimum mixture ratio example, makes main ingredient and adjuvant phase
It is more preferable to play effect for mutually cooperation.
Embodiment 12:
The present embodiment and embodiment 11 the difference is that: by the composition for being used for jasmine tea halogen component and master
Medicine: adjuvant takes determining value.
The composition for jasmine tea halogen of the present embodiment, raw material in parts by weight, including main ingredient and adjuvant, wherein main ingredient
Including 50 parts of dark green tea, 50 parts of green tea, 50 parts of jasmine tea, 50 parts of osmanthus flower tea, 50 parts of tartary buckwheat tea, 50 parts of spun gold emperor chrysanthemum tea, gold and silver
50 parts of jasmine tea, 50 parts of roselle, 50 parts of lycium ruthenicum, 50 parts of jujube, 30 parts of Siraitia grosvenorii, 30 parts of Radix Glycyrrhizae, 30 parts of fig, dried orange peel 50
Part, 30 parts of Radix Astragali, 30 parts of the sterculia seed and 100 parts of Radix Ophiopogonis；
50 parts of black tea, green 50 parts of tea, 50 parts of yellow tea, 50 parts of white tea, 50 parts of magnolia tea, 50 parts of lily tea, dried peppermint leaf
50 parts of tea, 50 parts of mulberry leaf, 50 parts of cape jasmine, 30 parts of red fructus lycii, 20 parts of Radix Angelicae Sinensis, 50 parts of amaranth reality, 30 parts of cassia seed, 50 parts of Radix Codonopsis and medicine
50 parts of osmanthus；
In use, main ingredient: adjuvant=2:1.
In the present embodiment, the content of each component in the composition for being used for jasmine tea halogen is set as occurrence, passed through
It designs in this way, performing to the synergistic effect between each component most preferably makes the composition for jasmine tea halogen reach best
Effect
Embodiment 13:
As shown in Figure 1, the production method of the composition for jasmine tea halogen, comprising the following steps:
S101: it takes and prepares raw material for any proportion in the composition of jasmine tea halogen described in claim 1-6；
S102: it is put into being packed after main ingredient cleaning in slaughterhouse, being stewed slowly with small fire makes the pharmacological property of the main ingredient penetrate into soup
In；
S103: it is put into being packed after adjuvant cleaning in slaughterhouse, being stewed slowly with small fire makes the pharmacological property of the adjuvant penetrate into soup
In；
S104: after the head soup that the main ingredient stews the head soup of system and the adjuvant stews system is outwelled, by the main ingredient of pack and
The adjuvant of pack is put into the same slaughterhouse and is stewed slowly with small fire；
S105: pot takes out the main ingredient and the adjuvant after making.
In the present embodiment, user is provided according to factors such as own situation, the favorite mouthfeels of institute relative to above-described embodiment
The amount of each component carry out increase appropriate or reduction.
In S101, raw material are prepared according to any proportion of the composition for jasmine tea halogen, are carried out later
Weighing and classification；In S102, main ingredient is handled, i.e., the main ingredient after cleaning is packed and is put into slaughterhouse and carry out infusion；
In S103, adjuvant is handled, processing step is similar to the processing of S102 squadron main ingredient, i.e., packs the adjuvant after cleaning
And it is put into infusion in slaughterhouse；By the processing of S102, S103, main ingredient and adjuvant
In S104, after the head soup of infusion before outwelling, main ingredient and adjuvant is put into the same slaughterhouse and carry out infusion, is obtained
To required millet paste；In S105, after millet paste pot makes, main ingredient and adjuvant are taken out, reduce the presence of impurity in millet paste,
Guarantee the mouthfeel of millet paste.
Meanwhile the pretreatment that main ingredient and adjuvant are taken in S102, S103, clear water infusion can be used, is needed in S104
Infusion millet paste is wanted, what is put in slaughterhouse is to have endured well-done soup before, and main ingredient and adjuvant carry out pot system in soup, sufficiently
Pharmacological property is penetrated into soup, soup is made to have both the pharmacological property of main ingredient, adjuvant on the basis of original nutritional ingredient, and then becomes required
The millet paste wanted.
Embodiment 14:
The present embodiment is on the basis of embodiment 13, the cleaning method supplemented with main ingredient and adjuvant.
The cleaning of the main ingredient and the adjuvant is used after impregnating 10min with warm water after clear water is cleaned.
The cleaning of the main ingredient and the adjuvant includes two steps: slightly being washed, will be adsorbed on each component using clear water
Soil, cauline leaf or other impurity wash, reach each component on surface without apparent impurity；Later by each group sub-dip
Bubble settles the impurity on each component surface by the time of immersion in warm water, while warm water temperature is high, is conducive to molecule fortune
It is dynamic, the sedimentation of impurity is accelerated, keeps the impurity on each component less by warm water immersion, each component is cleaner.
The small fire is 98-110 DEG C, and slow stew is infusion 50-70min.
Small fire stews slowly guarantees that various beneficiating ingredients can penetrate into soup in raw material, while guaranteeing that the nutritional ingredient in soup will not
It is denaturalized because of prolonged infusion.
It is further to note that specific technical features described in the above specific embodiments, in not lance
In the case where shield, it can be combined in any appropriate way.In order to avoid unnecessary repetition, the disclosure to it is various can
No further explanation will be given for the combination of energy.
The present invention is not limited to above-mentioned optional embodiment, anyone can show that other are various under the inspiration of the present invention
The product of form, however, make any variation in its shape or structure, it is all to fall into the claims in the present invention confining spectrum
Technical solution, be within the scope of the present invention.
Claims (9)
1. being used for the composition of jasmine tea halogen, it is characterised in that: raw material in parts by weight, including main ingredient and adjuvant, wherein principal cartridge
Include 40-60 parts of dark green tea, 40-60 parts of green tea, 40-60 parts of jasmine tea, 40-60 parts of osmanthus flower tea, 40-60 parts of tartary buckwheat tea, spun gold emperor
40-60 parts of chrysanthemum tea, 20-40 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum, 40-60 parts of jujube, Siraitia grosvenorii 20-
40 parts, 20-40 parts of Radix Glycyrrhizae, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali, 20-40 parts of the sterculia seed and Radix Ophiopogonis 90-
110 parts；
Adjuvant include 40-60 parts of black tea, green 40-60 parts of tea, 40-60 parts of yellow tea, 40-60 parts of white tea, 40-60 parts of magnolia tea,
40-60 parts of lily tea, 40-60 parts of mint-leaf tea, 40-60 parts of mulberry leaf, 40-60 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis 10-
40-60 parts of 30 parts, 40-60 parts of amaranth reality, 20-40 parts of cassia seed, 40-60 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
2. the composition according to claim 1 for jasmine tea halogen, it is characterised in that: raw material in parts by weight, including master
Medicine and adjuvant, wherein main ingredient include 45-55 parts of dark green tea, 45-55 parts of green tea, 45-55 parts of jasmine tea, 45-55 parts of osmanthus flower tea,
45-55 parts of tartary buckwheat tea, 45-55 parts of spun gold emperor's chrysanthemum tea, 25-35 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum,
40-60 parts of jujube, 20-40 parts of Siraitia grosvenorii, 20-40 parts of Radix Glycyrrhizae, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali,
20-40 parts and Radix Ophiopogonis 90-110 parts of the sterculia seed；
Adjuvant include 45-55 parts of black tea, green 45-55 parts of tea, 45-55 parts of yellow tea, 45-55 parts of white tea, 45-55 parts of magnolia tea,
45-55 parts of lily tea, 45-55 parts of mint-leaf tea, 40-60 parts of mulberry leaf, 40-60 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis 10-
40-60 parts of 30 parts, 40-60 parts of amaranth reality, 20-40 parts of cassia seed, 40-60 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
3. the composition according to claim 2 for jasmine tea halogen, it is characterised in that: raw material in parts by weight, including master
Medicine and adjuvant, wherein main ingredient include 45-55 parts of dark green tea, 45-55 parts of green tea, 45-55 parts of jasmine tea, 45-55 parts of osmanthus flower tea,
45-55 parts of tartary buckwheat tea, 45-55 parts of spun gold emperor's chrysanthemum tea, 25-35 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum,
40-60 parts of jujube, 25-35 parts of Siraitia grosvenorii, 20-40 parts of Radix Glycyrrhizae, 20-40 parts of fig, 40-60 parts of dried orange peel, 20-40 parts of Radix Astragali,
25-35 parts and Radix Ophiopogonis 95-105 parts of the sterculia seed；
Adjuvant include 45-55 parts of black tea, green 45-55 parts of tea, 45-55 parts of yellow tea, 45-55 parts of white tea, 45-55 parts of magnolia tea,
45-55 parts of lily tea, 45-55 parts of mint-leaf tea, 45-55 parts of mulberry leaf, 45-55 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis 10-
40-60 parts of 30 parts, 40-60 parts of amaranth reality, 25-35 parts of cassia seed, 40-60 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
4. the composition according to claim 3 for jasmine tea halogen, it is characterised in that: raw material in parts by weight, including master
Medicine and adjuvant, wherein main ingredient include 45-55 parts of dark green tea, 45-55 parts of green tea, 45-55 parts of jasmine tea, 45-55 parts of osmanthus flower tea,
45-55 parts of tartary buckwheat tea, 45-55 parts of spun gold emperor's chrysanthemum tea, 25-35 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum,
40-60 parts of jujube, 25-35 parts of Siraitia grosvenorii, 25-35 parts of Radix Glycyrrhizae, 20-40 parts of fig, 45-55 parts of dried orange peel, 25-35 parts of Radix Astragali,
25-35 parts and Radix Ophiopogonis 95-105 parts of the sterculia seed；
Adjuvant include 45-55 parts of black tea, green 45-55 parts of tea, 45-55 parts of yellow tea, 45-55 parts of white tea, 45-55 parts of magnolia tea,
45-55 parts of lily tea, 45-55 parts of mint-leaf tea, 45-55 parts of mulberry leaf, 45-55 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis 15-
40-60 parts of 25 parts, 45-55 parts of amaranth reality, 25-35 parts of cassia seed, 45-55 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=1.5:1-2.5:1.
5. the composition according to claim 4 for jasmine tea halogen, it is characterised in that: raw material in parts by weight, including master
Medicine and adjuvant, wherein main ingredient include 45-55 parts of dark green tea, 45-55 parts of green tea, 45-55 parts of jasmine tea, 45-55 parts of osmanthus flower tea,
45-55 parts of tartary buckwheat tea, 45-55 parts of spun gold emperor's chrysanthemum tea, 25-35 parts of honeysuckle tea, 40-60 parts of roselle, 40-60 parts of lycium ruthenicum,
40-60 parts of jujube, 25-35 parts of Siraitia grosvenorii, 25-35 parts of Radix Glycyrrhizae, 20-40 parts of fig, 45-55 parts of dried orange peel, 25-35 parts of Radix Astragali,
25-35 parts and Radix Ophiopogonis 95-105 parts of the sterculia seed；
Adjuvant include 45-55 parts of black tea, green 45-55 parts of tea, 45-55 parts of yellow tea, 45-55 parts of white tea, 45-55 parts of magnolia tea,
45-55 parts of lily tea, 45-55 parts of mint-leaf tea, 45-55 parts of mulberry leaf, 45-55 parts of cape jasmine, fructus lycii 20-40 parts red, Radix Angelicae Sinensis 15-
40-60 parts of 25 parts, 45-55 parts of amaranth reality, 25-35 parts of cassia seed, 45-55 parts of Radix Codonopsis and medicine osmanthus；
In use, main ingredient: adjuvant=2:1.
6. the composition according to claim 5 for jasmine tea halogen, it is characterised in that: raw material in parts by weight, including master
Medicine and adjuvant, wherein main ingredient includes 50 parts of dark green tea, 50 parts of green tea, 50 parts of jasmine tea, 50 parts of osmanthus flower tea, 50 parts of tartary buckwheat tea, gold
50 parts of silk emperor chrysanthemum tea, 50 parts of honeysuckle tea, 50 parts of roselle, 50 parts of lycium ruthenicum, 50 parts of jujube, 30 parts of Siraitia grosvenorii, 30 parts of Radix Glycyrrhizae,
30 parts of fig, 50 parts of dried orange peel, 30 parts of Radix Astragali, 30 parts of the sterculia seed and 100 parts of Radix Ophiopogonis；
50 parts of black tea, green 50 parts of tea, 50 parts of yellow tea, 50 parts of white tea, 50 parts of magnolia tea, 50 parts of lily tea, mint-leaf tea 50
Part, 50 parts of mulberry leaf, 50 parts of cape jasmine, 30 parts of red fructus lycii, 20 parts of Radix Angelicae Sinensis, 50 parts of amaranth reality, 30 parts of cassia seed, 50 parts of Radix Codonopsis and medicine osmanthus 50
Part；
In use, main ingredient: adjuvant=2:1.
7. the production method of the composition for jasmine tea halogen, it is characterised in that: the following steps are included:
S101: it takes and prepares raw material for any proportion in the composition of jasmine tea halogen described in claim 1-6；
S102: it is put into being packed after main ingredient cleaning in slaughterhouse, being stewed slowly with small fire penetrates into the pharmacological property of the main ingredient in soup；
S103: it is put into being packed after adjuvant cleaning in slaughterhouse, being stewed slowly with small fire penetrates into the pharmacological property of the adjuvant in soup；
S104: after the head soup that the main ingredient stews the head soup of system and the adjuvant stews system is outwelled, by the main ingredient of pack and pack
Adjuvant be put into the same slaughterhouse and stewed slowly with small fire；
S105: pot takes out the main ingredient and the adjuvant after making.
8. the production method of the composition according to claim 7 for jasmine tea halogen, it is characterised in that: the main ingredient and institute
The cleaning for stating adjuvant is used after impregnating 10min with warm water after clear water is cleaned.
9. the production method of the composition according to claim 7 for jasmine tea halogen, it is characterised in that: the small fire is
98-110 DEG C, slow stew is infusion 50-70min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910098965.1A CN109674014A (en) | 2019-01-31 | 2019-01-31 | Composition and production method for jasmine tea halogen |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910098965.1A CN109674014A (en) | 2019-01-31 | 2019-01-31 | Composition and production method for jasmine tea halogen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109674014A true CN109674014A (en) | 2019-04-26 |
Family
ID=66195528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910098965.1A Pending CN109674014A (en) | 2019-01-31 | 2019-01-31 | Composition and production method for jasmine tea halogen |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109674014A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112841575A (en) * | 2021-02-08 | 2021-05-28 | 湖南华诚生物资源股份有限公司 | Soft edible areca and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101385529A (en) * | 2008-10-17 | 2009-03-18 | 吴永田 | Guilin rice-flour noodle brine |
| CN105725093A (en) * | 2016-03-11 | 2016-07-06 | 云南农业大学 | Mate for red meat processing and cooking |
-
2019
- 2019-01-31 CN CN201910098965.1A patent/CN109674014A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101385529A (en) * | 2008-10-17 | 2009-03-18 | 吴永田 | Guilin rice-flour noodle brine |
| CN105725093A (en) * | 2016-03-11 | 2016-07-06 | 云南农业大学 | Mate for red meat processing and cooking |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112841575A (en) * | 2021-02-08 | 2021-05-28 | 湖南华诚生物资源股份有限公司 | Soft edible areca and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105432839B (en) | A kind of slim tea and preparation method thereof | |
| CN101695328A (en) | Dendrobium tea | |
| CN104323153A (en) | Health food with function of reducing hyperpiesia, hyperglycaemia and hyperlipemia | |
| CN102363011B (en) | Chinese medicinal composition for dispel effects of alcohol, and preparation method thereof | |
| CN104940645A (en) | Dendrobium officinale traditional Chinese medicine composition with functions of maintaining beauty and keeping young and preparation of dendrobium officinale traditional Chinese medicine composition | |
| CN107751993A (en) | A kind of antifatigue cream taste and preparation method thereof | |
| CN104887900A (en) | Health care wine with effects of fat reducing and weight losing | |
| CN106343091A (en) | Weight-loss herbal tea beverage and preparation method thereof | |
| CN104109609A (en) | Glutinous rice wine buckwheat juice beverage and preparation method thereof | |
| CN104336213A (en) | Glossy ganoderma health-care tea and preparation method thereof | |
| CN102293290B (en) | Tea capable of digesting and smoothing intestine and preparation method thereof | |
| CN103652845A (en) | Soup capable of relieving summer-heat, reducing fat and beautifying face | |
| CN109674014A (en) | Composition and production method for jasmine tea halogen | |
| CN109480014A (en) | A kind of trollflower rose beauty tea and preparation method thereof | |
| CN101558879B (en) | Teabag containing paeoniifolia for calming and tranquilizing mind and manufacturing method thereof | |
| CN103250829A (en) | Lotus plumule tea beverage | |
| CN106418015A (en) | Formula and making method of dietetic invigoration beverage with clearing and regulating functions | |
| CN106804794A (en) | A kind of health protection tea with Weight-reducing and lipid-lowering defaecation effect | |
| CN104306817A (en) | Pharmaceutical composition for treating ephemeral fever of dairy cow and preparation method thereof | |
| CN109010518A (en) | Blood-pressure decreasing tea and its preparation method and application method | |
| CN109172694A (en) | Blood-pressure decreasing tea and its preparation method and application method | |
| CN109010516A (en) | Blood-pressure decreasing tea and its preparation method and application method | |
| CN114600988B (en) | Stomach-nourishing and uterus-warming plant beverage | |
| CN101502621B (en) | Nutrient solution for cleaning blood and softening blood vessel | |
| CN105795033A (en) | Beauty-maintaining skin-caring healthcare Pu-erh tea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190426 |